Increased red blood cell sodium-lithium countertransport (SLC) activity and elevated intracellular calcium have been observed in hypertensive patients. The association of these ion transport abnormalities with each other and with another phenotype, insulin resistance, has been suggested. We investigated whether elevated SLC activity and increased lymphocyte cytosolic calcium (Ca cyt ) occur in the same individuals and whether either is associated with hyperinsulinaemia. We measured SLC activity, lymphocyte Ca cyt and fasting insulin levels in hypertensive patients and normal subjects. Consistent with prior studies, SLC activity was significantly and positively correlated with fasting insulin levels (r = 0.45, P Ͻ 0.01). However, SLC activity and lymphocyte Ca cyt were significantly but inversely correlated (r = −0.42, P Ͻ 0.01) and lymphocyte Ca cyt was also inversely correlated with fasting insulin (r = −0.55, P Ͻ
Introduction
Attempts to understand the pathogenesis of essential hypertension have focused on the identification of intermediate phenotypes. A number of abnormalities in the regulation of intracellular ions in blood cells from hypertensive patients have been identified. One of the best-characterised intermediate phenotypes in this regard is increased activity of sodium-lithium countertransport (SLC) in red blood cells. 1 The presence of this ion transport abnormality is also a phenotypic marker for risk of developing hypertension. 2, 3 0.001). When the study participants were instead separated into two groups based on fasting insulin levels, those above the median (15 U/ml) had significantly higher SLC activity and significantly lower Ca cyt . When separated by lymphocyte Ca cyt levels (above or below 120 nM) those patients with low lymphocyte Ca cyt had significantly higher SLC activity and significantly higher insulin levels. Multiple linear regression showed that fasting insulin was significantly predictive of SLC activity (P = 0.05) and Ca cyt (P Ͻ 0.01). Thus, elevated SLC activity and increased lymphocyte Ca cyt are separate and distinct ion transport phenotypes in hypertensive patients, linked through a relationship to hyperinsulinaemia that is direct with SLC activity and inverse with lymphocyte Ca cyt . Elevated red blood cell SLC may reflect or be associated with other phenotypic abnormalities in hypertensive patients. For example, an association between elevated SLC activity and insulin resistance has been shown. 4, 5 In support of this observation we showed that insulin stimulates SLC activity in vitro, which may be a mechanism for elevated SLC activity in insulin-resistant individuals. 6 However, SLC activity may be affected by other intracellular processes such as protein kinase C (PKC) 7 and cell calcium. 8 In this regard, increased cell calcium is present in red blood cells, platelets and lymphocytes from hypertensive patients [9] [10] [11] [12] and has a multimodal distribution in hypertensives. 12 Cell calcium may also be modulated by insulin 13 and increased intracellular calcium has been associated with insulin resistance. 14 Thus, we hypothesised that a relationship between elevated SLC activity and increased lymphocyte Ca cyt would be present.
Despite their frequent occurrence in hypertensive patients, red blood cell SLC activity and cell calcium measurements have not been simultaneously investigated in the same individuals. This report examines their relationship in hypertensive and normal individuals and compares each with a separate phenotype, fasting insulin levels, which has been related to both. We examined whether increased lymphocyte Ca cyt and elevated red blood cell SLC activity occur in the same individuals or represent separate and unique phenotypes in essential hypertension.
Methods

Study protocol
Patients with essential hypertension and normotensive individuals were recruited from Boston (17 normal subjects and 17 hypertensives) and Padova (five normal subjects and 26 hypertensives). Patients and normal subjects were recruited from the outpatient clinics of both facilities and there was no active attempt to match subjects. Participants were excluded from the study if they had other significant concomitant diseases such as diabetes mellitus, renal or hepatic disease, or a recent cardiovascular event (within 1 year). All patients with essential hypertension were withdrawn from antihypertensive medication for at least 3 weeks prior to study. Hypertensive subjects had blood pressure measured in the sitting position after 5 min rest and were required to have systolic blood pressure у140 mm Hg and/or diastolic blood pressure у90 mm Hg. Informed, written consent was obtained before each person's participation.
Blood samples for SLC, lymphocyte Ca cyt and insulin levels (measured by radioimmunoassay) were obtained in the morning after overnight fast. All samples were processed within 1 h after collection and studied locally using identical validated protocols and not on preserved blood samples. For technical reasons, six patients did not have SLC activity measurements despite having cell calcium and insulin measurements. We validated the reproducibility of the assays used in Boston and Padova, by measuring SLC activity and Ca cyt in blood samples obtained locally from the same subjects (n = 3); in each, the coefficient of variation was 10% or less.
Sodium-lithium countertransport activity
The red blood cell sodium-lithium countertransport activity assay measures the transport of Li + coupled to a Na + gradient and it is expressed as external Na +stimulated Li + efflux. The method for measurement used in these studies was previously described by Canessa. 1,5
Lymphocyte cytosolic Ca 2+ measurement
Human lymphocytes were isolated from whole blood as previously described. 12 Steady-state levels of cytosolic calcium (Ca cyt ) were determined using the fluorescent probe, fura-2. The Ca cyt concentration was calculated as described by Tsien et al. 15 Basal Ca cyt levels were reported after a 60 s recording period. All determinations were performed in duplicate for each patient. Trypan blue exclusion as a measure of cell viability was typically Ͼ90%.
Statistical analyses
The data are reported as mean ± standard error. All data were analysed using unpaired t-tests (for demographic variables), analysis of variance (for multiple comparisons) or linear and multiple regression (to determine association between variables) where appropriate. All statistical analyses were performed with the SigmaStat software program (Jandel Scientific, San Raphael, CA, USA), and P values р0.05 were regarded as statistically significant.
Results
The clinical characteristics of the study group are shown in Table 1 . Patients with essential hypertension did not differ by age, weight or gender from the normotensive individuals. Measurements of SLC activity, lymphocyte Ca cyt fasting insulin levels and blood pressure in hypertensive patients and normal subjects are summarised in Table 2 . Confirming previous observations, we found that both SLC activity and lymphocyte Ca cyt were significantly higher in hypertensive patients when compared with the normal subjects (Table 2 ). There was no significant correlation between mean blood pressure and lymphocyte Ca cyt as previously reported 12 likely due to the multimodal distribution of lymphocyte Ca cyt among hypertensives. A weak but significant correlation (r = 0.29, P Ͻ 0.05) was observed between mean blood pressure and SLC. The mean fasting insulin level was higher in hypertensives but did not differ significantly from the normal subjects. 
Relationships between SLC activity and lymphocyte cytosolic calcium
It has been previously shown that elevated intracellular calcium increases the activity of red blood cell SLC activity. 5, 8 Although we were clearly studying different cell types, red blood cells and lymphocytes, we hypothesised that a positive, linear relationship would also be present. However, we observed a significant but inverse correlation between lymphocyte Ca cyt and SLC activity (r = −0.42, P Ͻ 0.01) in hypertensive patients (Figure 1) . While there was a significant relationship between lymphocyte Ca cyt and SLC activity, the discriminating ability for SLC to predict lymphocyte Ca cyt was low due to variability in the distribution of lymphocyte Ca cyt in the hypertensive patients. We previously described a multimodal distribution of Ca cyt in hypertensives that separated at a level of 120 nM. 12 We examined SLC activity in hypertensive patients with Ca cyt above and below Figure 1 Red blood cell sodium-lithium countertransport activity and lymphocyte cytosolic calcium in hypertensive patients.
Journal of Human Hypertension 120 nM. Demographic characteristics in these subgroups were not different from one another nor were they different from the normal subjects. Blood pressure was similar in the two hypertensive subgroups. Hypertensive patients with high Ca cyt had SLC activity similar to normal subjects and significantly (P Ͻ 0.05) lower than the patients with low Ca cyt ( Table 2) .
Relationships between insulin, SLC activity and lymphocyte cytosolic calcium
We examined the relationships between SLC activity, lymphocyte Ca cyt and fasting insulin levels. Consistent with prior observations, we found a significant correlation between SLC activity and fasting insulin levels (r = 0.45, P Ͻ 0.01) in hypertensive patients (Figure 2 ). There was no significant relationship in normal subjects. There was also a significant relationship between SLC activity and body weight (r = 0.46, P Ͻ 0.01) in hypertensives, but this was likely due to the common relationship with fasting insulin that was revealed by multiple linear regression. There was a significant but inverse relationship between lymphocyte Ca cyt and insulin (r = −0.55, P Ͻ 0.001) ( Figure 3 ). Again, despite this significant relationship the discriminating ability for insulin to predict lymphocyte Ca cyt was low.
We examined insulin levels in individuals with lymphocyte Ca cyt above or below 120 nM and found that the low Ca cyt group had significantly higher insulin levels (P Ͻ 0.05) ( Table 2 ) when compared with high Ca cyt hypertensives and normal subjects. We also examined this relationship by comparing individuals above and below the median of fasting insulin (15 U/ml). Those hypertensives with high insulin levels had significantly (P Ͻ 0.01) elevated SLC activity (Figure 4 , panel a) and significantly (P = 0.017) lower Ca cyt levels (Figure 4, panel b) , although there was considerable overlap between the groups. To further determine whether each variable (insulin, Ca cyt and SLC activity) was an independent predictor of the other, we performed multiple linear regression. Fasting insulin was significantly predictive of SLC activity (P = 0.05) and Ca cyt (P Ͻ 0.01).
Discussion
The results of our study show that elevated lymphocyte Ca cyt and elevated red blood cell SLC activity are separate and distinct ion transport phenotypes in hypertensive patients. Both are indirectly linked through a relationship to fasting insulin levels that is negative for lymphocyte Ca cyt and positive for SLC Figure 4 Levels of SLC activity (panel a) and lymphocyte cytosolic calcium (panel b) for normotensive (᭺) and hypertensive (᭹) individuals above and below the median for fasting insulin (15 U/ml). Data points are from those subjects that had simultaneous measurements of SLC or cytosolic calcium and fasting insulin levels from the same blood draw. activity. Increased SLC activity and elevated fasting insulin levels were associated with low lymphocyte Ca cyt in the hypertensive patients that we studied. This relationship was revealed by comparing hypertensive patients with high and low Ca cyt or high and low fasting insulin levels. Multiple linear regression analysis suggested that insulin was independently and significantly predictive of both lymphocyte Ca cyt and SLC. These results are contrary to the suggestions that elevated intracellular calcium is associated with hyperinsulinaemia and insulin resistance. 14, 16 A possible link between elevated cell calcium and insulin resistance is based on observations in which elevated cell calcium in red blood cells (measured with nuclear magnetic resonance) was present in hypertensive patients and cell calcium was shown to increase with insulin incubation. 17 Additionally, elevated insulin levels in vivo (using the hyperinsulinaemic clamp) were shown to increase platelet calcium concentrations in insulin-resistant hypertensive patients. 18 Our studies are at variance with these prior findings but are in agreement with other's observations. Mattiasson et al 19 reported that insulin sensitivity directly correlates with SLC but not with platelet free calcium concentrations and Delva et al 20 reported insulin sensitivity correlates with lymphocyte-free free magnesium but not with free calcium.
Certainly, insulin has pleiotropic effects on membrane and intracellular calcium transport pathways that might lower Ca cyt . Insulin stimulates both the plasma membrane Ca-ATPase and the sarcoplasmic (endoplasmic) reticulum Ca-ATPase. [21] [22] [23] Insulininduced increases in the activity of either pathway could be associated with lower intracellular calcium in insulin sensitive patients. In support of this hypothesis, we have observed that hypertensives with high Ca cyt have a substantial fall in Ca cyt with insulin incubation in vitro (unpublished observations). If such a fall in Ca cyt similarly occurred in vascular smooth muscle cells (VSMC), particularly in insulin-sensitive individuals, this may be associated with reduced VSMC contraction. Indeed, this is consistent with insulin's vasodilating properties in normal individuals and with graded amounts of insulin-induced vasodilation in hypertensives grouped by levels of insulin sensitivity. 24 However, levels of or changes in Ca cyt cannot be solely responsible for the state of smooth muscle contraction. As an example of this, the hypertensives with low Ca cyt clearly have a process ongoing that sustains their higher level of blood pressure, which may not be calcium mediated. In contrast, the effect of insulin on SLC activity may be more clearly explained, based on in vitro data that show direct effects of insulin on SLC. We previously showed that insulin stimulates human red cell SLC in vitro at concentrations (50-100 U/ml), similar to those found in patients with insulin resistance. 16 In addition to studies in peripheral lymphocytes, increased Ca cyt has also been reported in platelets and erythrocytes 9,10 from patients with essential hypertension. While these observations speak to a more generalised abnormality, we felt that neither platelets nor red blood cells were appropriate for studying cell calcium. Platelets are not ideal for the study of ion transport mechanisms due to their lability with in vitro manipulations and high concentrations of haemoglobin in red blood cells significantly interfere with the emitted signal from fluorescent probes such as fura-2. 25 Therefore, we chose to study peripheral lymphocytes because they represent a more stable cell population and have been more frequently used for such studies. We did not measure red cell Ca cyt nor lymphocyte SLC in these experiments to see if the same cell types shared similar phenotypes, since it was not our goal to establish that the lymphocytes and red cells have the same ion transport events. However, in a previous report we showed that lymphocyte Na + -H + exchange is elevated in hypertensive patients 12 and a number of previous studies have confirmed elevated Ca cyt in red cells from hypertensive patients. 9, 26 It is not clear what mechanism(s) mediate the in vitro phenomenon of elevated red cell SLC activity or increased Ca cyt in hypertensive patients. However, elevated SLC activity is not only present in patients with essential hypertension but also in patients with diabetic nephropathy and is a predictor of progression to microalbuminuria in nondiabetics. [27] [28] [29] No links of cell calcium abnormalities to target organ damage or clinical manifestations of cardiovascular disease have been reported. Since we observed an inverse relationship between Ca cyt and SLC activity, by extrapolation this may imply that high Ca cyt is not a marker for the development of end Journal of Human Hypertension organ damage. Clearly, further studies are needed to further refine this hypothesis.
In conclusion, these results provide evidence that increased lymphocyte Ca cyt and elevated SLC activity are unique ion transport phenotypes in essential hypertension. However, both SLC activity and lymphocyte Ca cyt are linked through a common relationship to fasting insulin which is direct for SLC activity and inverse for Ca cyt .
